Indole, indazole and indoline derivatives as CETP inhibitors
申请人:Conte-Mayweg Aurelia
公开号:US20060030613A1
公开(公告)日:2006-02-09
The present invention relates to compounds of formula (I):
wherein —X—Y—, R
1
to R
11
and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are mediated by CETP inhibitors.
Disclosed herein are modulators of TRPV3 of Formula (I)
wherein p is 1, 2, 3, or 4, and G
1
, X
1
, X
2
, X
3
, X
4
, X
5
, G
2
, Z
1
, R
a
, R
b
, and u are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.
[EN] NOVEL TRPV3 MODULATORS<br/>[FR] NOUVEAUX MODULATEURS DE TRPV3
申请人:ABBOTT LAB
公开号:WO2012019315A1
公开(公告)日:2012-02-16
Disclosed herein are modulators of TRPV3 of formula (I), wherein G1, X1, X2, X3, X4, X5, G2, Z1, Ra, Rb, u, and p are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.
The present invention provides pyrazole and pyrazolone derivatives. Preferred compounds of the invention are useful as RNA polymerase inhibitors. Further preferred compounds of the invention are useful as antimicrobial agents.
The object of this invention is to provide an illuminant, which can easily be produced at low cost. This invention is a carbazole derivative luminescent compound having a carbazole ring skeleton, to the nitrogen atom of which is attached an electron-donating group, and to the carbon atom of which is attached an electron-attracting group at the third position to the nitrogen atom.